Paul S. Appelbaum, MD
Elizabeth K. Dollard Professor
Director, Division of Law, Ethics & Psychiatry, Department of Psychiatry
Paul S. Appelbaum, M.D., the Elizabeth K. Dollard Professor of Psychiatry, Medicine and Law, and Director, Division of Law, Ethics and Psychiatry at Columbia, was previously A.F. Zeleznik Distinguished Professor and Chairman, Department of Psychiatry; and Director, Law and Psychiatry Program, University of Massachusetts Medical School.
Dr. Appelbaum is the author of many articles and books on law and ethics in clinical practice. Dr. Appelbaum is Past President of the American Psychiatric Association, the American Academy of Psychiatry and the Law, and the Massachusetts Psychiatric Society, and has twice served as Chair of the Council on Psychiatry and Law and of the Committee on Judicial Action for the American Psychiatric Association (APA). Dr. Appelbaum is currently Chair of the DSM Steering Committee for APA, and of the Standing Committee on Ethics of the World Psychiatric Association. He has received the Isaac Ray Award of the American Psychiatric Association for "outstanding contributions to forensic psychiatry and the psychiatric aspects of jurisprudence," was the Fritz Redlich Fellow at the Center for Advanced Study in the Behavioral Sciences, and has been elected to the Institute of Medicine of the National Academy of Sciences. Dr. Appelbaum performs forensic evaluations in civil and criminal cases, and treats patients with a broad variety of problems, including depression, anxiety, and adjustment problems.
Neurological Institute of New York
710 West 168th Street
Floor: 12 New York, NY 10032
Public Transportation: Yes
Disabled Access: Yes
Dr. Appelbaum's research focuses on how legal and ethical rules affect medical practice and research, including informed consent, decisional capacity, mandatory treatment, advance directives, and confidentiality. He has a special interest in ethical and legal implications of neuropsychiatric genetics.
Dr. Appelbaum is involved in funded projects examining: functioning of IRBs at major medical centers around the country; therapeutic misconception in consent to research; use of behavioral genetic data in the courts; the consequences of returning genomic data to research subjects; unrealistic optimism in consent to medical research; use of N-of-1 trials; and impact of genetic conceptualizations of illness in Africa. He leads a NHGRI-funded center for research on ethical, legal, and social implications of psychiatric, neurologic and behavioral genetics.